Benjamin Fryer, PhD

Founder & CEO

Ben Fryer received his Doctorate in Pharmacology from the University of Pennsylvania Medical School. He has spent 18 years in industrial research, including 14 years as a stem cell scientist on projects ranging from basic research, to translational R&D and clinical manufacturing.  He is experienced in cross-functional team management, technical transfers to GMP environment, and managing large and diverse teams. Dr. Fryer has multiple issued and pending patents regarding processing, expanding and differentiating stems cells, and is a co-inventor on the foundational patent application for Semma Therapeutics, Inc.

Follow

©2018 by Pluristyx, Inc. All Rights Reserved.